PIA
ABMD

Piedmont Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Piedmont Investment Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,757
Closed -$691K – 751
2020
Q1 		$691K Buy
4,757
+557
+13% +$92.5K 0.03% 368
2019
Q4 		$716K Buy
4,200
+221
+6% +$41K 0.02% 414
2019
Q3 		$708K Buy
3,979
+71
+2% +$15.3K 0.03% 404
2019
Q2 		$1.02M Buy
3,908
+103
+3% +$27.3K 0.04% 322
2019
Q1 		$1.09M Buy
3,805
+51
+1% +$16.9K 0.04% 279
2018
Q4 		$1.22M Buy
3,754
+216
+6% +$75K 0.06% 245
2018
Q3 		$1.59M Buy
3,538
+3,059
+639% +$1.21M 0.07% 232
2018
Q2 		$196K Buy
+479
New +$174K 0.01% 849

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Piedmont Investment Advisors's ABMD Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 4,757 shares — an estimated $691K sold.

Piedmont Investment Advisors first reported a position in ABMD in Q2 2018 and held it in 8 quarters. The position peaked at $1.59M in Q3 2018. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 4,757 Abiomed Inc shares in Q2 2020, an estimated $691K.
  • Piedmont Investment Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 8 quarters.
  • Piedmont Investment Advisors's Abiomed Inc position peaked at $1.59M in Q3 2018.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.